Agendia´s clinical and scientific board consists of the following outstanding scientists and clinicians.

Piet Borst, M.D., PhD (chairman)

Emeritus Director of The Netherlands Cancer Institute and Emeritus Professor of Clinical Biochemistry, Amsterdam, The Netherlands

C. Kent Osborne, M.D.

Professor of Medicine and Director of the Breast Center Baylor College of Medicine, Houston, Texas, USA

Matt van de Rijn, M.D., Ph.D

Professor of the Pathology Department, Stanford University, School of Medicine, Stanford, CA, USA

Joe W. Gray, Ph.D.

Professor of the UCSF Comprehensive Cancer Center and Director of the Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA

Jose Baselga M.D.

Professor of Medicine and Chairman of the Medical Oncology Service, Vall d'Hebron University Hospital, Barcelona, Spain

David Kerr M.D.

Professor of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, Oxford, UK